IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,565,391 | -1.6% | 344,042 | +52.3% | 0.04% | +2.7% |
| Q2 2023 | $1,590,399 | -36.3% | 225,909 | -44.7% | 0.04% | -49.3% |
| Q1 2023 | $2,495,788 | -30.6% | 408,476 | -27.5% | 0.07% | -28.4% |
| Q4 2022 | $3,598,433 | -44.2% | 563,135 | -16.4% | 0.10% | -46.3% |
| Q3 2022 | $6,453,000 | -12.0% | 673,626 | +1.4% | 0.19% | -7.8% |
| Q2 2022 | $7,336,000 | +1.6% | 664,448 | +53.3% | 0.21% | +20.5% |
| Q1 2022 | $7,217,000 | -8.4% | 433,458 | +5.0% | 0.17% | +3.0% |
| Q4 2021 | $7,878,000 | -24.7% | 412,700 | -2.7% | 0.17% | -29.1% |
| Q3 2021 | $10,461,000 | +6.7% | 424,201 | +12.5% | 0.23% | +10.9% |
| Q2 2021 | $9,807,000 | +727.6% | 376,919 | +906.9% | 0.21% | +779.2% |
| Q1 2021 | $1,185,000 | -38.0% | 37,433 | -9.1% | 0.02% | -44.2% |
| Q4 2020 | $1,911,000 | +39.6% | 41,192 | -1.0% | 0.04% | +10.3% |
| Q3 2020 | $1,369,000 | +19.0% | 41,589 | -0.8% | 0.04% | +18.2% |
| Q2 2020 | $1,150,000 | -7.7% | 41,908 | +0.7% | 0.03% | -28.3% |
| Q1 2020 | $1,246,000 | -14.5% | 41,628 | -21.0% | 0.05% | +27.8% |
| Q4 2019 | $1,458,000 | +50.8% | 52,665 | -0.9% | 0.04% | +50.0% |
| Q3 2019 | $967,000 | -47.2% | 53,126 | -28.8% | 0.02% | -44.2% |
| Q2 2019 | $1,830,000 | – | 74,651 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |